Real-world comparative effectiveness of rivaroxaban versus heparin and phenprocoumon for the treatment and secondary prevention of venous thromboembolism (RECENT)

First published 30/06/2020

Last updated 23/04/2024

EU PAS number:

EUPAS36102

Study

Finalised

Documents

Study protocol

Initial protocol

21456_EU PAS_study protocol

English (2.71 MB - PDF)View document

Study results

21456_EU PAS Register_Abstract

English (442.55 KB - PDF)View document

Study report

OS_Report_21456_RECENT_FINAL_redacted

English (3.7 MB - PDF)View document

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs